Copaxone in therapy of remittent disseminated sclerosis patients

Twenty three remittent disseminated sclerosis patients have been observed for two years to study the influence of copaxone on clinical manifestations and course of their disease in relation to the state of membrane- destabilizing processes in erythrocytes.

Bibliographic Details
Main Authors: O. A. Kitcherova, L. I. Reikhert, S. M. Bychenko, A. A. Sokolova
Format: Article
Language:English
Published: Siberian State Medical University (Tomsk) 2008-09-01
Series:Бюллетень сибирской медицины
Subjects:
Online Access:https://bulletin.ssmu.ru/jour/article/view/3503
_version_ 1797873265476108288
author O. A. Kitcherova
L. I. Reikhert
S. M. Bychenko
A. A. Sokolova
author_facet O. A. Kitcherova
L. I. Reikhert
S. M. Bychenko
A. A. Sokolova
author_sort O. A. Kitcherova
collection DOAJ
description Twenty three remittent disseminated sclerosis patients have been observed for two years to study the influence of copaxone on clinical manifestations and course of their disease in relation to the state of membrane- destabilizing processes in erythrocytes.
first_indexed 2024-04-10T01:12:22Z
format Article
id doaj.art-cb2d7f32baff4a74bfb3fcfdbe53098f
institution Directory Open Access Journal
issn 1682-0363
1819-3684
language English
last_indexed 2024-04-10T01:12:22Z
publishDate 2008-09-01
publisher Siberian State Medical University (Tomsk)
record_format Article
series Бюллетень сибирской медицины
spelling doaj.art-cb2d7f32baff4a74bfb3fcfdbe53098f2023-03-13T09:58:08ZengSiberian State Medical University (Tomsk)Бюллетень сибирской медицины1682-03631819-36842008-09-017310411010.20538/1682-0363-2008-3-104-1102149Copaxone in therapy of remittent disseminated sclerosis patientsO. A. Kitcherova0L. I. Reikhert1S. M. Bychenko2A. A. Sokolova3Тюменская государственная медицинская академияТюменская государственная медицинская академияТюменская государственная медицинская академияТюменская государственная медицинская академияTwenty three remittent disseminated sclerosis patients have been observed for two years to study the influence of copaxone on clinical manifestations and course of their disease in relation to the state of membrane- destabilizing processes in erythrocytes.https://bulletin.ssmu.ru/jour/article/view/3503рассеянный склерозкопаксонперекисное окисление липидов
spellingShingle O. A. Kitcherova
L. I. Reikhert
S. M. Bychenko
A. A. Sokolova
Copaxone in therapy of remittent disseminated sclerosis patients
Бюллетень сибирской медицины
рассеянный склероз
копаксон
перекисное окисление липидов
title Copaxone in therapy of remittent disseminated sclerosis patients
title_full Copaxone in therapy of remittent disseminated sclerosis patients
title_fullStr Copaxone in therapy of remittent disseminated sclerosis patients
title_full_unstemmed Copaxone in therapy of remittent disseminated sclerosis patients
title_short Copaxone in therapy of remittent disseminated sclerosis patients
title_sort copaxone in therapy of remittent disseminated sclerosis patients
topic рассеянный склероз
копаксон
перекисное окисление липидов
url https://bulletin.ssmu.ru/jour/article/view/3503
work_keys_str_mv AT oakitcherova copaxoneintherapyofremittentdisseminatedsclerosispatients
AT lireikhert copaxoneintherapyofremittentdisseminatedsclerosispatients
AT smbychenko copaxoneintherapyofremittentdisseminatedsclerosispatients
AT aasokolova copaxoneintherapyofremittentdisseminatedsclerosispatients